Skip to content

Clinical Evidence-Based Evaluation of Acupuncture for Alleviating Cancer-Related Fatigue in Lung Cancer Patients

Clinical Evidence-Based Evaluation of Acupuncture for Alleviating Cancer-Related Fatigue in Lung Cancer Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000912
Enrollment
Unknown
Registered
2026-04-09
Start date
2025-11-01
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Sponsors

Chengdu Pidu District Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age 18–80 years; 2.Western medical diagnosis meeting the diagnostic criteria for lung cancer; 3.Meeting the diagnostic criteria for cancer-related fatigue (CRF) with CRF occurring after confirmed lung cancer diagnosis and persisting =1 month due to the malignancy or cancer-related therapies; 4.Expected survival period >6 months; 5.Karnofsky Performance Status (KPS) score =60; 6.No use of medications potentially affecting efficacy evaluation within 1 week prior to enrollment; 7.Conscious capable of effective communication and completing assessments as scheduled and voluntarily signed the Informed Consent Form. Participants must meet all the above criteria for enrollment.

Exclusion criteria

Exclusion criteria: 1. Severe dysfunction of major organs (e.g., heart, liver, or kidney). 2. Infectious diseases such as hepatitis B, HIV, or syphilis; severe pulmonary infection; or active systemic infections. 3. Recent major surgery or planned major surgical intervention. 4. History of needle fainting, severe skin disorders, or local infection at acupuncture points. 5. Pregnant or lactating women. 6. Comorbid psychiatric disorders, or history of substance/alcohol dependence. 7. Previous participation in other interventional clinical trials. 8. Cognitive impairment or speech-language barriers that preclude independent or assisted completion of questionnaires. 9. Concurrent enrollment in another clinical study.Participants meeting any one of the above criteria will be excluded.

Design outcomes

Primary

MeasureTime frame
multidimensional fatigue inventory;

Secondary

MeasureTime frame
Self-Rating Depression Scale;European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30+Lung Cancer 13;Self-Rating Anxiety Scale;Revised Piper Fatigue Scale;Brief Pain Inventory - Short Form;Grip Strength Test;Cortisol;

Countries

China

Contacts

Public ContactLi Ying

Chengdu University of Tradirional Chinese Medicine

liying@cdutcm.edu.cn15528352023

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026